Postoperative Radiotherapy +/- Cetuximab for Intermediate-Risk Head and Neck Cancer. Machtay M, Torres-Saavedra PA, Thorstad W, Nguyen-Tan PF, et al. J Clin Oncol 2025 Jan 22:JCO2401829. doi: 10.1200/JCO-24-01829.

Read + Share

Amedeo Smart

Independent Medical Education

Machtay M, Torres-Saavedra PA, Thorstad W, Nguyen-Tan PF, et al. Postoperative Radiotherapy +/- Cetuximab for Intermediate-Risk Head and Neck Cancer. J Clin Oncol 2025 Jan 22:JCO2401829. doi: 10.1200/JCO-24-01829.
PMID: 39841939